Monday, January 26, 2026
HomeIndustriesHealthcare

Healthcare

Avacta Announces AVA6000 Receives Orphan Drug Designation From the US FDA

Avacta Group plc, a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION™ platforms, announces that...

FDA-approved Investigator Clinical Trial of LAmbre Plus LAA Closure System

LifeTech Scientific Corporation is pleased to announce that on 30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre Plus Left...

Ibex Announces Galen 3.0 Cancer Diagnostics Platform

Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, announced the launch and roll-out of Galen 3.0, a transformative solution offering new detection capabilities...

Onera Launches Innovative Sleep Diagnostics Solution in Europe

Onera Health, a leader in transforming sleep medicine and remote monitoring, announced today the official launch of its ground-breaking solution to diagnose sleep disorders...

Slingshot Biosciences, Partners With BIOKÉ to Distribute Synthetic Cells

SLINGSHOT BIOSCIENCES, INC., the makers of synthetic control cells for cell analysis applications, including flow cytometry, enabling precise, reliable, and repeatable results, today announced...
0FansLike
0FollowersFollow
spot_img

Hot Topics